Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07065721 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

A NA study of Type 2 Diabetes Mellitus (T2DM), sponsored by San Diego State University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07065721: Recruiting NA study of Type 2 Diabetes Mellitus (T2DM), sponsored by San Diego State University.

NCT07065721 is a NA study of Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by San Diego State University. The registered enrollment target is 40 participants, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07065721, a NA study of Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by San Diego State University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.

Primary Outcome

Semi-structured qualitative interviews will be conducted to understand barriers and facilitators of CGM use, changes in awareness of glucose patterns or relationships between glucose and health behaviors, and preferences for a future CGM-based intervention.

Interventions

  • DEVICE Continuous glucose monitor

Study Locations (1)

California

  • Scripps Health - San Diego

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-10-02
Est. Completion 2026-07-30
Phase NA
San Diego State University

118 total trials

What NCT07065721 shows while recruiting

NCT07065721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Type 2 Diabetes Mellitus (T2DM) appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitor is the first listed.

NCT07065721 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07065721 about?

NCT07065721 is a clinical study titled "Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults". Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitator...

What is the current status of trial NCT07065721?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-10-02. Estimated completion is 2026-07-30.

What conditions does trial NCT07065721 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus (T2DM).

What interventions are being tested in trial NCT07065721?

The interventions under investigation include: Continuous glucose monitor (DEVICE).

Who is sponsoring clinical trial NCT07065721?

This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07065721 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus (T2DM)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07065721's enrollment target sits among peer trials

40 20th of 24 higher than 3 of 24 other Type 2 Diabetes Mellitus (T2DM) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus (T2DM) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07065721, the US trial registry maintained by the National Library of Medicine. NCT07065721 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.